✦ LIBER ✦

Aspirin and compression devices versus low-molecular-weight heparin and PCD for VTE prophylaxis in orthopedic oncology patients

✍ Scribed by Anay R. Patel; Martha K. Crist; Jason Nemitz; Joel L. Mayerson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinically significant thromboembolic di

✍ Pietro Ruggieri; Maurizio Montalti; Elisa Pala; Andrea Angelini; Teresa Calabrò; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Clinically significant thromboembolic di

✍ Thomas Scharschmidt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Low molecular weight heparin started bef

✍ J. Daniš; D. Bergqvist 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

Low molecular weight heparin started bef

✍ Professor D. Bergqvist; U. S. Burmark; P. A. Flordal; J. Frisell; T. Hallböökr; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB